Skip to main
STXS

Stereotaxis Inc (STXS) Stock Forecast & Price Target

Stereotaxis Inc (STXS) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Stereotaxis Inc. is projected to experience substantial revenue growth, with forecasts indicating increases of 24% for system sales and 25% for disposables, driven by the adoption of new systems and catheter utilization. In the second quarter of FY26, the company reported a 95% year-over-year increase in revenue, reaching $8.8 million, while recurring revenue rose 35% to $5.8 million, underscoring strong demand for robotic-assisted procedures. Additionally, significant regulatory advancements related to the company's next-generation robotic systems and catheters are expected to enhance revenue streams and operational leverage, further supporting optimistic financial projections for FY26.

Bears say

Stereotaxis Inc. faces a challenging financial outlook due to several key factors affecting its performance. The company reported a net loss of $3.8 million, with ongoing cash runway issues indicating a need for additional financing, which could dilute shareholder value. Furthermore, potential delays in product approvals, supply chain challenges, and competitive pressures from alternative approaches in the market could hinder revenue growth and further complicate efforts to achieve profitability.

Stereotaxis Inc (STXS) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Stereotaxis Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Stereotaxis Inc (STXS) Forecast

Analysts have given Stereotaxis Inc (STXS) a Buy based on their latest research and market trends.

According to 2 analysts, Stereotaxis Inc (STXS) has a Buy consensus rating as of Jan 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $4, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $4, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Stereotaxis Inc (STXS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.